A Case of Drug-induced Linear IgA Bullous Dermatosis
暂无分享,去创建一个
[1] S. Jenkins,et al. Piperacillin-Tazobactam-Resistant/Third-Generation Cephalosporin-Susceptible Escherichia coli and Klebsiella pneumoniae Isolates: Resistance Mechanisms and In vitro-In vivo Discordance. , 2020, International journal of antimicrobial agents.
[2] C. Mclean,et al. Piperacillin–tazobactam‐induced linear IgA bullous dermatosis presenting clinically as Stevens–Johnson syndrome/toxic epidermal necrolysis overlap , 2017, Clinical and experimental dermatology.
[3] M. Rybak,et al. Pneumonia Caused by Methicillin-Resistant Staphylococcus aureus: Does Vancomycin Heteroresistance Matter? , 2016, Antimicrobial Agents and Chemotherapy.
[4] A. Bygum,et al. Linear IgA bullous dermatosis: a retrospective study of 23 patients in Denmark. , 2015, Acta dermato-venereologica.
[5] C. Jaworsky,et al. Linear IgA Bullous Disease Presenting as Toxic Epidermal Necrolysis: A Case Report and Review of the Literature , 2013, Dermatology.
[6] Amin Fazeli,et al. Vancomycin‐induced linear IgA disease manifesting as bullous erythema multiforme , 2004, Journal of cutaneous pathology.
[7] G. Ogg,et al. Vancomycin‐induced linear IgA disease with autoantibodies to BP180 and LAD285 , 2001, The British journal of dermatology.
[8] M. Beylot-Barry,et al. Drug-induced linear IgA bullous dermatosis. , 1995, Journal of the American Academy of Dermatology.